Mark Lupher
Direttore/Membro del Consiglio presso ADVERUM BIOTECHNOLOGIES, INC.
Patrimonio netto: 102 960 $ in data 31/05/2024
Posizioni attive di Mark Lupher
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 01/05/2019 | - |
| Independent Dir/Board Member | 01/05/2019 | - | |
| VeritasRx Consulting | Fondatore | 01/01/2013 | - |
| Presidente | 01/01/2013 | - |
Storia della carriera di Mark Lupher
Precedenti posizioni note di Mark Lupher
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 09/03/2016 | 01/03/2020 |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Direttore Tecnico/Scientifico/R&S | 01/06/2010 | 01/06/2013 |
| Corporate Officer/Principal | 01/01/2007 | 23/02/2011 | |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01/10/1998 | 01/02/2007 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | - | - |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Formazione di Mark Lupher
| Harvard University | Doctorate Degree |
| University of Washington | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
Posizioni
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Health Technology |
| VeritasRx Consulting |
- Borsa valori
- Insiders
- Mark Lupher
- Esperienza
